ArticleDose-response : a publication of International Hormesis Society

Efficacy and Safety of Sintilimab in Combination With Anlotinib and Chemoradiotherapy as First-Line Treatment for Driver Gene-Negative Oligometastatic Non-small Cell Lung Cancer: A Real-World Cohort Study.

Jian Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.